PW MEDTECH (01358) spent HKD 640,900 to repurchase 436,000 shares on October 24th.
PwC Consulting (01358) announced that on October 24, 2025, the company invested HKD 640,900...
PW MEDTECH (01358) announced on October 24, 2025, that the company will repurchase 436,000 shares at a cost of HK$640,900, with a repurchase price of HK$1.47 per share.
Related Articles
Hong Kong stocks rise as Beijing vows stronger tech self-reliance and domestic support
US Stock Market Move | Teladoc Health (TDOC.US) rises more than 9% after receiving a target price increase from Bank of America.
US Stock Market Move | Alphabet Inc. Class C (GOOGL.US) rose nearly 3%, deeply binding with Anthropic to build a computational moat.
Hong Kong stocks rise as Beijing vows stronger tech self-reliance and domestic support
US Stock Market Move | Teladoc Health (TDOC.US) rises more than 9% after receiving a target price increase from Bank of America.
US Stock Market Move | Alphabet Inc. Class C (GOOGL.US) rose nearly 3%, deeply binding with Anthropic to build a computational moat.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
